Iranian Journal of Pediatrics

Published by: Kowsar

Potential of Serum and Urinary Matrix Metalloproteinase-9 Levels for the Early Detection of Renal Involvement in Children With Henoch-Schönlein Purpura

Meltem Erol 1 , * , Ozgul Yigit 1 , Mehmet Tasdemir 2 , Ozlem Bostan Gayret 1 , Ovgu Buke 1 , Aysegul Gunes 3 , Sahin Hamilcikan 1 and Ozgur Kasapcopur 4
Authors Information
1 Department of Pediatrics, Bagcilar Training and Research Hospital, Istanbul, Turkey
2 Department of Pediatric Nephology, Koc University Hospital, Istanbul, Turkey
3 Department of Biochemistry, Bagcilar Training and Research Hospital, Istanbul, Turkey
4 Department of Pediatric Rheumatology, Cerrahpasa Medical Faculty, Istanbul University, Istanbul, Turkey
Article information
  • Iranian Journal of Pediatrics: August 2016, 26 (4); e6129
  • Published Online: June 5, 2016
  • Article Type: Research Article
  • Received: March 25, 2016
  • Revised: April 19, 2016
  • Accepted: May 10, 2016
  • DOI: 10.5812/ijp.6129

To Cite: Erol M, Yigit O, Tasdemir M, Bostan Gayret O, Buke O, et al. Potential of Serum and Urinary Matrix Metalloproteinase-9 Levels for the Early Detection of Renal Involvement in Children With Henoch-Schönlein Purpura, Iran J Pediatr. 2016 ; 26(4):e6129. doi: 10.5812/ijp.6129 .

Abstract
Copyright © 2016, Growth & Development Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnote
References
  • 1. Yi ZW, Fang XL, Wu XC, He XJ, He QN, Dang XQ, et al. Role of PAX2 gene polymorphisms in Henoch-Schonlein purpura nephritis. Nephrology (Carlton). 2006; 11(1): 42-8[DOI][PubMed]
  • 2. Lau KK, Suzuki H, Novak J, Wyatt RJ. Pathogenesis of Henoch-Schonlein purpura nephritis. Pediatr Nephrol. 2010; 25(1): 19-26[DOI][PubMed]
  • 3. Davin JC, Weening JJ. Henoch-Schonlein purpura nephritis: an update. Eur J Pediatr. 2001; 160(12): 689-95[PubMed]
  • 4. Kawasaki Y, Ono A, Ohara S, Suzuki Y, Suyama K, Suzuki J, et al. Henoch-Schonlein purpura nephritis in childhood: pathogenesis, prognostic factors and treatment. Fukushima J Med Sci. 2013; 59(1): 15-26[PubMed]
  • 5. de Almeida JL, Campos LM, Paim LB, Leone C, Koch VH, Silva CA. Renal involvement in Henoch-Schonlein purpura: a multivariate analysis of initial prognostic factors. J Pediatr (Rio J). 2007; 83(3): 259-66[DOI][PubMed]
  • 6. Hung SH, Yang YH, Lee CC, Wang LC, Lin YT, Chiang BL. Clinical predictors of self-limited urinalysis abnormality in childhood Henoch-Schonlein purpura nephritis. Acta Paediatr. 2006; 95(3): 306-11[DOI][PubMed]
  • 7. Qin YH, Zhou TB, Lei FY, Huang WF, Zhao YJ, Lin FQ, et al. Cut-off values for serum matrix metalloproteinase-9: is there a threshold to predict renal involvement for Henoch-Schonlein purpura in children? Nephrology (Carlton). 2011; 16(1): 93-9[DOI][PubMed]
  • 8. Lenz O, Elliot SJ, Stetler-Stevenson WG. Matrix metalloproteinases in renal development and disease. J Am Soc Nephrol. 2000; 11(3): 574-81[PubMed]
  • 9. Catania JM, Chen G, Parrish AR. Role of matrix metalloproteinases in renal pathophysiologies. Am J Physiol Renal Physiol. 2007; 292(3)-11[DOI][PubMed]
  • 10. Ma H, Lin H, Ma G. Urinary levels of collagen IV and MMP-9 and their clinical significances in children with Henoch–Schonlein purpura. Med Innov Res. 2008; 5: 8-9
  • 11. Wang SM, Qi X, Pan T, Xu L. The Relationship between Urinary Microprotein and Metalloproteinase-9 Expression in Children with Nephritis of Schonle-Henoch Purpura. J Hubei Univ Med. 2010; 29: 515-7
  • 12. Li C, Chen Q, Zhang Y, Wang M, Ke P. Changes and clinical significance of matrix metalloproteinase-9 in children with Henoch–Schonlein purpura nephritis. Guangdong Med J. 2011; 32: 2945–6
  • 13. Zhu QY, Jiang YH, Liu JD, Sun Q. Significance of Changes of Serum Levels and Ratios of Matrix Nephritis Metalloproteinase-2,-9 and Tissue Inhibitor of Metalloproteinase-1 in Children with Henoch-Schonlein Purpura Nephristis. J Appl Clin Pediatr. 2007; 22(5): 343-4
  • 14. Caim W, Li A, Chen S, Li C, Cui H. Clinical significance of the change of matrix metalloproteinase-9 children with Henoch-Schönlein purpura nephritis. Shandong Med J . 2007; 47: 42-3
  • 15. Wang YB AS. Matrix metalloproteinase 2, 9 and its tissue inhibitor 1 expression and their significance in the Henoch–Schönlein purpura nephritis. Harbin Med J. 2009; 29: 13-4
  • 16. Lu Y. The clinical significance of the detection of matrix metalloproteinase 9 in children with Henoch–Schönlein purpura nephritis. Mod Pract Med. 2010; 22: 1178-80
  • 17. Yu Z, Peng X. The changes and clinical significance of IL-6, IL-8, MMP-9 in serum of children with Henoch–Schönlein purpura nephritis. T Hebei Med. 2008; 14: 573-6
  • 18. Geng XH, Zhang H. Relationship between Matrix Metalloproteinase Level and Kidney Damage in Children with Henoch-Schonlein Purpura Nephritis. J Henan Univ Sci Tech (Med Sci). 2011; 29: 100-2
  • 19. Ozen S, Ruperto N, Dillon MJ, Bagga A, Barron K, Davin JC, et al. EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis. 2006; 65(7): 936-41[DOI][PubMed]
  • 20. McLennan SV, Fisher E, Martell SY, Death AK, Williams PF, Lyons JG, et al. Effects of glucose on matrix metalloproteinase and plasmin activities in mesangial cells: possible role in diabetic nephropathy. Kidney Int Suppl. 2000; 77-7[PubMed]
  • 21. Tveita A, Rekvig OP, Zykova SN. Glomerular matrix metalloproteinases and their regulators in the pathogenesis of lupus nephritis. Arthritis Res Ther. 2008; 10(6): 229[DOI][PubMed]
  • 22. Sanders JS, van Goor H, Hanemaaijer R, Kallenberg CG, Stegeman CA. Renal expression of matrix metalloproteinases in human ANCA-associated glomerulonephritis. Nephrol Dial Transplant. 2004; 19(6): 1412-9[DOI][PubMed]
  • 23. Danilewicz M, Wagrowska-Danilewicz M. Differential glomerular immunoexpression of matrix metalloproteinases MMP-2 and MMP-9 in idiopathic IgA nephropathy and Schoenlein-Henoch nephritis. Folia Histochem Cytobiol. 2010; 48(1): 63-7[DOI][PubMed]
  • 24. Tashiro K, Koyanagi I, Ohara I, Ito T, Saitoh A, Horikoshi S, et al. Levels of urinary matrix metalloproteinase-9 (MMP-9) and renal injuries in patients with type 2 diabetic nephropathy. J Clin Lab Anal. 2004; 18(3): 206-10[DOI][PubMed]
  • 25. Shin JI, Song KS, Kim H, Cho NH, Kim J, Kim HS, et al. The gene expression profile of matrix metalloproteinases and their inhibitors in children with Henoch-Schonlein purpura. Br J Dermatol. 2011; 164(6): 1348-55[DOI][PubMed]
  • 26. Zhou TB, Yin SS. Association of matrix metalloproteinase-9 level with the risk of renal involvement for Henoch-Schonlein purpura in children. Ren Fail. 2013; 35(3): 425-9[DOI][PubMed]
  • 27. Zou CC, Zhao ZY, Tang LF, Liang L. Plasma levels of matrix metalloproteinase-9 in Henoch-Schonlein purpura. Scand J Rheumatol. 2006; 35(1): 52-5[DOI][PubMed]
  • 28. Ebihara I, Nakamura T, Shimada N, Koide H. Increased plasma metalloproteinase-9 concentrations precede development of microalbuminuria in non-insulin-dependent diabetes mellitus. Am J Kidney Dis. 1998; 32(4): 544-50
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments